Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Renata Borawska
Observed name:
R Borawska
Institution:
Medical University of Białystok
Observed institution:
Medical University of Białystok
ORCID:
0000-0002-0448-2209
Observed ORCID:
0000-0002-0448-2209
OpenAlex ID:
A5010922115
Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease
2014
·
Barbara Mroczko
, Magdalena Groblewska
, et al.
·
Journal of Alzheimer s Disease
·
43
The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer’s Disease
2017
·
Paweł Muszyński
, Agnieszka Kulczyńska-Przybik
, et al.
·
Journal of Alzheimer s Disease
·
42
Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease
2021
·
Maciej Dulewicz
, Agnieszka Kulczyńska-Przybik
, et al.
·
Journal of Clinical Medicine
·
32
PDF
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia
2020
·
Agnieszka Kulczyńska-Przybik
, Agnieszka Słowik
, et al.
·
Current Alzheimer Research
·
32
Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
2021
·
Maciej Dulewicz
, Agnieszka Kulczyńska-Przybik
, et al.
·
Journal of Clinical Medicine
·
30
PDF
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
2021
·
Agnieszka Kulczyńska-Przybik
, Maciej Dulewicz
, et al.
·
Journal of Clinical Medicine
·
23
PDF
The cerebrospinal fluid interleukin 8 (IL‐8) concentration in Alzheimer’s disease (AD)
2021
·
Julia Doroszkiewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
16
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
2023
·
Julia Doroszkiewicz
, Agnieszka Kulczyńska-Przybik
, et al.
·
Journal of Clinical Medicine
·
15
Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease
2024
·
Julia Doroszkiewicz
, Agnieszka Kulczyńska-Przybik
, et al.
·
International Journal of Molecular Sciences
·
14
The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
2023
·
Agnieszka Kulczyńska-Przybik
, Maciej Dulewicz
, et al.
·
International Journal of Molecular Sciences
·
14
Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
2022
·
Maciej Dulewicz
, Agnieszka Kulczyńska-Przybik
, et al.
·
International Journal of Molecular Sciences
·
10
PDF
Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
2022
·
Agnieszka Kulczyńska-Przybik
, Maciej Dulewicz
, et al.
·
Journal of Clinical Medicine
·
7
PDF
The assessment of ubiquitin C‐terminal hydrolase‐1 (UCH‐L1) in patients with Alzheimer’s disease
2022
·
Agnieszka Kulczynska‐Przybik
, Maciej Dulewicz
, et al.
·
Alzheimer s & Dementia
·
6
The significance of the Calbindin‐D in Alzheimer’s disease
2023
·
Barbara Mroczko
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
4
PDF
The neuronal pentraxin receptor (NPTXR) as a candidate biomarker of synaptic dysfunction in mild cognitive impairment
2023
·
Maciej Dulewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
4
PDF
Significance of some tumor markers in differential diagnosis of ovarian tumor.
1999
·
I Zakrzewska
, R Borawska
, et al.
·
PubMed
·
4
The cerebrospinal fluid Neutrophil gelatinase‐associated lipocalin (NGAL) concentration in Alzheimer’s Disease (AD)
2024
·
Julia Doroszkiewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
2
PDF
The cerebrospinal fluid Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) concentration in Alzheimer’s Disease (AD)
2023
·
Julia Doroszkiewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
2
PDF
Neurogranin: A novel biomarker of Alzheimer’s disease
2021
·
Maciej Dulewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
2
Significance of CXCL1 chemokine in the development of tau pathology
2025
·
Agnieszka Kulczynska‐Przybik
, Daria Krawczuk
, et al.
·
Alzheimer s & Dementia
·
1
PDF
Glial and synaptic biomarkers as early indicators of mild cognitive decline
2024
·
Agnieszka Kulczynska‐Przybik
, Maciej Dulewicz
, et al.
·
Alzheimer s & Dementia
·
1
PDF
The cerebrospinal fluid soluble TREM‐1 concentration in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)
2023
·
Julia Doroszkiewicz
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
1
PDF
The significance of reticulon‐4A in Parkinson’s disease
2021
·
Barbara Mroczko
, Agnieszka Kulczynska‐Przybik
, et al.
·
Alzheimer s & Dementia
·
1
Upregulation of microRNA‐451a in the blood of the patients with Alzheimer’s disease (AD)
2021
·
Agnieszka Kulczynska‐Przybik
, Maciej Dulewicz
, et al.
·
Alzheimer s & Dementia
·
1
P3‐077: Matrix metalloproteinase 9 (MMP‐9) in the cerebrospinal fluid (CSF) of patients with mild cognitive impairment (MCI)
2015
·
Pawel Muszynski
, Magdalena Groblewska
, et al.
·
Alzheimer s & Dementia
·
1
Show more works
View as search
Works count:
38
Citation count:
309
H-index:
10
I10-index:
11
Year
Topic
Type